Home News

From critic to chief: Carolin Schumacher begins to shape GALVmed strategy for 2030

Last year, Dr Carolin Schumacher joined our team as the new Chief Executive. She recently sat down with industry magazine Animal Pharm to talk about her aspirations and  how she is steering GALVmed towards providing better livestock health services to smallholder farmers. Read more on this insightful interview.  

GALVmed and Hester Biosciences conduct veterinary awareness week

To commemorate the 2019 World Veterinary Day whose theme was the Value of Vaccination, the Veterinary Social Business (VSB) division of Hester Biosciences Limited, a GALVmed partner in South Asia, recently conducted a weeklong livestock vaccination campaign. The seven-day campaign was an innovative awareness activity on the value of livestock vaccination. The campaign targeted all […]

African Vaccinology Network (AfVANET) Launched

Inaugural scientific workshop held from 19-20 March 2019 in Nairobi, Kenya During the Keystone Symposia in Cape Town (2016) African scientists set the base for establishing the African Vaccinology Network (AfVANET) as a forum for African scientists to take greater part in establishing priorities for vaccine development for emerging and re-emerging human and veterinary diseases […]

Hester launches production plant in Nepal

GALVmed partner, Hester Biosciences Ltd, has officially launched its animal health manufacturing plant in Nepal. The facility is expected to boost Hester’s role in providing animal health products to smallholder farmers in Nepal. GALVmed is currently in a partnership with Hester to develop a smallholder-focused animal health distribution network in Nepal and in the Indian […]

Reflections and new beginnings- A message from our CEO

Warm greetings and best wishes for a successful and prosperous 2019! While the New Year is still young, I would like to share with you some of the key moments for GALVmed in 2018 and update you on our plans for 2019. 2018 was a year rich in events at GALVmed. It marked the start […]

GALVmed, Hester and Bihar Rural Livelihoods Promotion Society sign MoU to accelerate delivery of livestock products

GALVmed, with its partner Hester Bioscience Limited has signed a new Memorandum of Understanding (MoU) with Bihar Rural Livelihoods Promotion Society (BRLPS) to accelerate vaccination of livestock against Peste des Petit Ruminants (PPR) and Newcastle Disease in the State of Bihar, India. GALVmed and Hester are currently working to develop a reliable and sustainable supply […]

Boehringer Ingelheim launches ‘LastMile’ initiative to address major barriers in animal healthcare sector in Sub-Saharan Africa

The initiative is established by Boehringer Ingelheim and supported by GALVmed Nairobi, Kenya – 4 July 2018– Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, announced today the launch of the ‘LastMile Initiative’, an integrated, solutions-driven program that seeks to address crucial animal health challenges by creating consistent availability of animal medical resources in […]

A message from our new Chief Executive, Carolin Schumacher

It is a great honour and pleasure for me to have been appointed as the new CEO of GALVmed. I join the organisation at a moment where GALVmed can look back proudly onto 10 years of successful operations and has established a solid foundation of experienced staff, strong partners and good funding. Let us stop […]

Funding for Tryps Phase 3 approved

GALVmed has received funding approval totalling to US$ 19 million for the Phase 3 programme on Improved Tools for the Control of Animal African Trypanosomosis (Tryps 3). The main objective of the programme, which is co-funded by the UK Government and Bill & Melinda Gates Foundation, is to commercially develop a registered therapeutic trypanocidal product […]

Peter Wells retires from GALVmed Board

In September 2018 Dr Peter Wells retired from GALVmed’s Board of Trustees. Peter became involved with GALVmed initially through the Expert Scientific Advisory Committee before involvement in the governance of GALVmed early 2011. After a brief period as interim CEO Peter was formally appointed as a trustee in April 2012. During his time as trustee […]

1 2 3 21